222 related articles for article (PubMed ID: 24009738)
1. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL
PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738
[TBL] [Abstract][Full Text] [Related]
2. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle.
Hornberger TA; Chu WK; Mak YW; Hsiung JW; Huang SA; Chien S
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4741-6. PubMed ID: 16537399
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of AMP-activated protein kinase and phospholipase D.
Mukhopadhyay S; Saqcena M; Chatterjee A; Garcia A; Frias MA; Foster DA
J Biol Chem; 2015 Mar; 290(11):6986-93. PubMed ID: 25632961
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells.
Liu Y; Fanburg BL
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L471-8. PubMed ID: 18621911
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes.
Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH
Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).
Foster DA; Salloum D; Menon D; Frias MA
J Biol Chem; 2014 Aug; 289(33):22583-22588. PubMed ID: 24990952
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA
Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling.
Jaafar R; De Larichaudy J; Chanon S; Euthine V; Durand C; Naro F; Bertolino P; Vidal H; Lefai E; Némoz G
Cell Commun Signal; 2013 Aug; 11():55. PubMed ID: 23915343
[TBL] [Abstract][Full Text] [Related]
9. Ca(2+)- and phospholipase D-dependent and -independent pathways activate mTOR signaling.
Ballou LM; Jiang YP; Du G; Frohman MA; Lin RZ
FEBS Lett; 2003 Aug; 550(1-3):51-6. PubMed ID: 12935885
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.
Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J
FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159
[TBL] [Abstract][Full Text] [Related]
12. Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation.
Scott SA; Xiang Y; Mathews TP; Cho HP; Myers DS; Armstrong MD; Tallman KA; O'Reilly MC; Lindsley CW; Brown HA
J Biol Chem; 2013 Jul; 288(28):20477-87. PubMed ID: 23723068
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
[TBL] [Abstract][Full Text] [Related]
14. Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.
El Osta M; Liu M; Adada M; Senkal CE; Idkowiak-Baldys J; Obeid LM; Clarke CJ; Hannun YA
FASEB J; 2014 Jan; 28(1):495-505. PubMed ID: 24121461
[TBL] [Abstract][Full Text] [Related]
15. mTOR signaling: PLD takes center stage.
Sun Y; Chen J
Cell Cycle; 2008 Oct; 7(20):3118-23. PubMed ID: 18927511
[TBL] [Abstract][Full Text] [Related]
16. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.
Shen Q; Stanton ML; Feng W; Rodriguez ME; Ramondetta L; Chen L; Brown RE; Duan X
Int J Clin Exp Pathol; 2010 Nov; 4(1):13-21. PubMed ID: 21228924
[TBL] [Abstract][Full Text] [Related]
17. The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium.
Margaria JP; Campa CC; De Santis MC; Hirsch E; Franco I
Cell Signal; 2020 Feb; 66():109468. PubMed ID: 31715259
[TBL] [Abstract][Full Text] [Related]
18. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
Foster DA
Biochim Biophys Acta; 2009 Sep; 1791(9):949-55. PubMed ID: 19264150
[TBL] [Abstract][Full Text] [Related]
20. The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy.
You JS; Lincoln HC; Kim CR; Frey JW; Goodman CA; Zhong XP; Hornberger TA
J Biol Chem; 2014 Jan; 289(3):1551-63. PubMed ID: 24302719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
